BRITTANY HAMBY: Open Payments
NPI 1023325180 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 69 payments from 16 companies in 2025. Trend: 2023 $1,566 · 2024 $1,337 · 2025 $1,699
Food & beverage: $1,699
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $387 |
| GENZYME CORPORATION | 10 | $222 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $173 |
| CSL Behring | 7 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $168 |
| Novartis Pharmaceuticals Corporation | 8 | $155 |
| BioCryst US Sales Co., LLC | 3 | $79 |
| Grifols USA, LLC | 3 | $64 |
| Amgen Inc. | 2 | $50 |
| Optinose US, Inc. | 2 | $49 |
Products named: DUPIXENT, NEFFY, Rhapsido, TAKHZYRO, ORLADEYO, Hizentra, Andembry, AYVAKIT.
Industry payments across TN — which companies pay providers there.
